
Soricimed Biopharma Inc. (Soricimed), formerly BioProspecting NB Inc. is a drug development company. The company carries out the development and commercialization of therapeutic and diagnostic programs. Its products under clinical development include SOR-C13, SO-C27, SOR-N54, SOR-D01, and SOR-D02. Soricimeds products are used in the treatment of ovarian, breast and prostate cancer, and other cancer types. The company also provides pain management technology. It partners with The Company and the Atlantic Cancer Research Institute, and BC Cancer Agency. The company has a service research agreement with NRC institutions including the NRC Institute for Biological Sciences, NRC Institute for Marine Biosciences, and the NRC Institute for Biodiagnostics. Soricimed is headquartered in Moncton, New Brunswick, Canada.